 |
|
Prospective Study of Postmenopausal Hormone Use and Newly Diagnosed Asthma and Chronic Obstructive Pulmonary Disease
R. Graham Barr, MD, DrPH;
Catherine C. Wentowski, MPH;
Francine Grodstein, ScD;
Samuel C. Somers, MD;
Meir J. Stampfer, MD, DrPH;
Joel Schwartz, PhD;
Frank E. Speizer, MD;
Carlos A. Camargo, Jr, MD, DrPH
Arch Intern Med. 2004;164:379-386.
Background Female reproductive hormones appear to influence asthma, although data are conflicting, and may modulate development of chronic obstructive pulmonary disease (COPD). Therefore, in a prospective cohort study, we evaluated whether postmenopausal hormone use was associated with an increased rate of newly diagnosed asthma and, separately, newly diagnosed COPD.
Methods Postmenopausal hormone use was assessed by questionnaire biennially from 1976 onward. New physician diagnoses of asthma or COPD were reported on questionnaires from 1988 to 1996 and confirmed in 1998 using supplementary questionnaires. Grades of diagnostic certainty were established from reports of medication use and pulmonary function using validated definitions.
Results During 546 259 person-years of follow-up, current use of estrogen alone was associated with an increased rate of asthma (multivariate rate ratio, 2.29; 95% confidence interval [CI], 1.59-3.29) compared with those who never used hormones. Current users of estrogen plus progestin had a similarly increased rate of newly diagnosed asthma. Rate ratios increased with certainty of diagnosis of asthma. In contrast, rates of newly diagnosed COPD were the same among hormone users and nonusers (multivariate rate ratio, 1.05; 95% CI, 0.80-1.37).
Conclusions Postmenopausal hormone use was associated with an increased rate of newly diagnosed asthma but not newly diagnosed COPD. Female reproductive hormones may contribute to the onset of asthma among adult women, but do not appear to hasten the development of COPD.
From the Channing Laboratory, Department of Medicine, Brigham & Women's Hospital (Drs Barr, Grodstein, Somers, Stampfer, Schwartz, Speizer, and Camargo and Ms Wentowski), the Division of General Medicine (Dr Barr), Department of Emergency Medicine (Dr Camargo), Massachusetts General Hospital, Harvard Medical School, and the Departments of Epidemiology (Drs Barr, Grodstein, Stampfer, and Camargo) and Environmental Health (Drs Schwartz and Speizer), Harvard School of Public Health, Boston, Mass; and the Division of General Medicine, Department of Medicine, College of Physicians & Surgeons, Columbia University, New York, NY (Dr Barr). Dr Grodstein has received honoraria from Novartis, Orion Pharma (Finland), Pfizer, and Schering-Plough.
RELATED LETTER
Postmenopausal Asthma: The Estradiol 11 -Hydroxysteroid Dehydrogenase Connection
Paul G. Cohen and John M. Holbrook
Arch Intern Med. 2004;164(22):2501.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Sexual Tension in the Airways: The Puzzling Duality of Estrogen in Asthma
Lim and Kobzik
Am. J. Respir. Cell Mol. Bio. 2008;38:499-500.
FULL TEXT
Gender and Chronic Obstructive Pulmonary Disease: Why It Matters
Han et al.
Am. J. Respir. Crit. Care Med. 2007;176:1179-1184.
ABSTRACT
| FULL TEXT
Association between leptin and asthma in adults
Sood et al.
Thorax 2006;61:300-305.
ABSTRACT
| FULL TEXT
Fruit and vegetable intakes and asthma in the E3N study
Romieu et al.
Thorax 2006;61:209-215.
ABSTRACT
| FULL TEXT
Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey
Gomez Real et al.
Thorax 2006;61:34-40.
ABSTRACT
| FULL TEXT
Sex Specificity of Asthma Associated With Objectively Measured Body Mass Index and Waist Circumference: The Humboldt Study
Chen et al.
Chest 2005;128:3048-3054.
ABSTRACT
| FULL TEXT
Relation between phase of the menstrual cycle and asthma presentations in the emergency department
Brenner et al.
Thorax 2005;60:806-809.
ABSTRACT
| FULL TEXT
Postmenopausal Asthma: The Estradiol 11{beta}-Hydroxysteroid Dehydrogenase Connection
Cohen and Holbrook
Arch Intern Med 2004;164:2501-2501.
FULL TEXT
|
